dr reddy glp 1 Dr. Reddy's Laboratories has received approval from Health Canada for its generic semaglutide injection, strengthening the Indian drugmaker's presence in the fast-growing global market for GLP-1 diabetes therapies. The company said on The Best Weight Loss Medication in the U.S Dr. Reddy’s Wins Canada Approval

Tribulova N, Knezl V, Shainberg A, Seki S, Soukup T

According to MEDVi's published terms, this assessment does not create a doctor-patient relationship between the individual and MEDVi

Target: ~ 150 minutes of moderate activity per week , including walking and light core movement. 4

Stephanie's takeaways Resources mentioned in this episode: We are grateful to our sponsors: KENETIK - You think carefully about how you fuel your body but are you fueling your brain

4 A history of gallbladder disease A 2022 systematic review of 76 randomised trials found that GLP-1 medications are associated with a relative risk of around 37% for gallbladder or biliary disease, with a higher relative risk in weight-loss trials than in diabetes trials

In this review, we aimed to provide a comprehensive summary of the potential relationship between anti-inflammatory effects of GLP-1 and CAD